Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 85
SponsorIstituto Ortopedico Rizzoli
About this trial
The goal of this observational study is to learn how tumor tissue and blood samples from patients with sarcomas or metastases can be used to create laboratory models that help researchers study cancer behavior and test new treatments. Participants diagnosed with sarcoma or with bone or lung metastases from solid tumors will donate leftover tumor tissue and blood collected during their regular medical care. These samples will be used in the lab to build 3D models of the tumor, test drugs, and identify genetic and molecular markers. No treatments or procedures will be given as part of the study.
Eligibility criteria
Qualifiers
Patients (male or female) diagnosed with sarcoma or with bone or lung metastases from solid tumors
Age between 0 and 85 years
Availability of sufficient and adequate biological material (tumor tissue and/or blood)
Signed informed consent for biobanking (BIOTUM)
Disqualifiers
Diagnosis other than sarcoma or metastases from solid tumors
Missing signed informed consent(s)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
125 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov